Embla Medical hf
CSE:EMBLA

Watchlist Manager
Embla Medical hf Logo
Embla Medical hf
CSE:EMBLA
Watchlist
Price: 35.3 DKK 2.32% Market Closed
Market Cap: 15.1B DKK
Have any thoughts about
Embla Medical hf?
Write Note

Net Margin
Embla Medical hf

8.2%
Current
7%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
8.2%
=
Net Income
69.1m
/
Revenue
840.3m

Net Margin Across Competitors

Country IS
Market Cap 15.1B DKK
Net Margin
8%
Country US
Market Cap 199B USD
Net Margin
14%
Country US
Market Cap 191.3B USD
Net Margin
29%
Country US
Market Cap 141.3B USD
Net Margin
16%
Country US
Market Cap 134.2B USD
Net Margin
11%
Country IE
Market Cap 104.6B USD
Net Margin
13%
Country US
Market Cap 65.6B USD
Net Margin
9%
Country DE
Market Cap 58.1B EUR
Net Margin
8%
Country US
Market Cap 44.5B USD
Net Margin
74%
Country CN
Market Cap 311.1B CNY
Net Margin
33%
Country US
Market Cap 36.3B USD
Net Margin
9%
No Stocks Found

Embla Medical hf
Glance View

Market Cap
15.1B DKK
Industry
Health Care

Embla Medical hf, a rising star in the medical device industry, has carved a niche in the sleep diagnostics sector with its innovative technology. Founded with the vision of transforming sleep health, the Iceland-based company specializes in developing advanced sleep diagnostic systems. These devices are crucial in identifying sleep disorders, a growing concern globally as awareness about sleep health continues to rise. Embla Medical’s flagship products are portable and user-friendly diagnostic tools that allow both clinicians and patients to monitor sleep patterns in real-time. By focusing on cutting-edge technology and accuracy, the company has established itself as a trusted partner in medical facilities worldwide, enhancing its reputation and solidifying its market presence. The business model of Embla Medical relies heavily on the research and development of its diagnostic systems, complemented by a strategic emphasis on customer service and support. The revenue stream is generated through the sale of these sophisticated devices to hospitals, sleep clinics, and directly to healthcare providers. Additionally, they offer ongoing maintenance services and software updates, providing a continuous source of income post-sale. By integrating software with hardware, they ensure that their equipment remains at the forefront of technological advancements in sleep diagnostics. This not only drives sales but also builds a loyal customer base that places high value on efficacy and ease of use. Embla Medical's focus on innovation and customer satisfaction positions them well to capitalize on the growing market for sleep healthcare solutions.

EMBLA Intrinsic Value
38.64 DKK
Undervaluation 9%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
8.2%
=
Net Income
69.1m
/
Revenue
840.3m
What is the Net Margin of Embla Medical hf?

Based on Embla Medical hf's most recent financial statements, the company has Net Margin of 8.2%.